Evidence map›Paper›PMID 33062594›Full record

ArticleJournal of translational internal medicine2020

Suppression of Inflammatory Cytokines Expression with Bitter Melon (

Asli Semiz, Ozden Ozgun Acar, Hulya Cetin, Gurkan Semiz, Alaattin Sen

Open access · hybridAbstract read
In one paragraph

Article in Journal of translational internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Antioxidants (Basel, Switzerland) · 2026
    Article
  2. Bioactive Compounds ofInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Molecules (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Review
  10. Animal Models and Pathogenesis of Ulcerative Colitis.Computational and mathematical methods in medicine · 2022
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Asli SemizPamukkale University, Faculty of Technology, Department of Biomedical Engineering, Denizli 20070, Turkey.
Ozden Ozgun AcarPamukkale University, Seed Breeding & Genetic Application and Research Centre Denizli 20070, Turkey.
Hulya CetinPamukkale University, Faculty of Medicine, Basic Medical Sciences-Histology and Embryology, Denizli 20070, Turkey.
Gurkan SemizPamukkale University, Faculty of Arts and Sciences, Biology Department, 20070 Denizli, Turkey.
Alaattin SenPamukkale University, Faculty of Arts and Sciences, Biology Department, 20070 Denizli, Turkey.
Pamukkale University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveThis study was aimed to elucidate the molecular mechanism of

methodsAfter the induction of the experimental colitis, the animals were treated with MCh (4 g/kg/day) for 14 consecutive days by intragastric gavage. The colonic tissue expression levels of C-C motif chemokine ligand 17 (CCL-17), interleukin (IL)-1β, IL-6, IL-23, interferon-γ (IFN-γ), nuclear factor kappa B (NF-kB), and tumor necrosis factor-α (TNF-α), were determined at both mRNA and protein levels to estimate the effect of

resultsThe body weights from TNBS-instigated colitis rats were found to be significantly lower than untreated animals. Also, the IFN-γ, IL-1β, IL-6, Il-23, TNF-α, CCL-17, and NF-kB mRNA and protein levels were increased significantly from 1.86-4.91-fold and 1.46-5.50-fold, respectively, in the TNBS-instigated colitis group as compared to the control. Both the MCh and prednisolone treatment significantly reduced the bodyweight loss. It also restored the induced colonic tissue levels of IL-1β, IL-6, IFN-γ, and TNF-α to normal levels seen in untreated animals. These results were also supported with the histochemical staining of the colonic tissues from both control and treated animals.

conclusionThe presented data strongly suggests that

Indexed as

alternative and complementary therapeuticsanti-inflammatoryCYP27B1immunohistochemistryinflammatory bowel diseaseinflammatory cytokinesMomordica charantiatrinitrobenzenesulfonic acidulcerative colitisvitamin D

Identifiers

PMID33062594
PMCPMC7534491
OpenAlexW3092677152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.